Detalles de la búsqueda
1.
Phenotype and predictors of insulin independence in adults presenting with diabetic ketoacidosis: a prospective cohort study.
Diabetologia
; 67(3): 494-505, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38240751
2.
A Phase 2A Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid, With or Without Aspirin, for Human Immunodeficiency Virus-Associated Tuberculous Meningitis: The LASER-TBM Trial.
Clin Infect Dis
; 76(8): 1412-1422, 2023 04 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36482216
3.
A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes.
Cardiovasc Diabetol
; 21(1): 158, 2022 08 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-35996147
4.
Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa.
Trop Med Int Health
; 27(6): 564-573, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35411997
5.
Dulaglutide and incident atrial fibrillation or flutter in patients with type 2 diabetes: A post hoc analysis from the REWIND randomized trial.
Diabetes Obes Metab
; 24(4): 704-712, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34984808
6.
Similar cardiovascular outcomes in patients with diabetes and established or high risk for coronary vascular disease treated with dulaglutide with and without baseline metformin.
Eur Heart J
; 42(26): 2565-2573, 2021 07 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33197271
7.
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Lancet
; 394(10193): 121-130, 2019 07 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-31189511
8.
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Lancet
; 394(10193): 131-138, 2019 07 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-31189509
9.
Total cardiovascular or fatal events in people with type 2 diabetes and cardiovascular risk factors treated with dulaglutide in the REWIND trail: a post hoc analysis.
Cardiovasc Diabetol
; 19(1): 199, 2020 11 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33239067
10.
The utility of a shortened palliative care screening tool to predict death within 12 months - a prospective observational study in two south African hospitals with a high HIV burden.
BMC Palliat Care
; 18(1): 101, 2019 Nov 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-31722691
11.
Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide.
Diabetes Obes Metab
; 20(1): 42-49, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28573765
12.
A description of the elevation of pericardial cortisol: cortisone ratio in patients with tuberculous pericarditis.
Front Endocrinol (Lausanne)
; 14: 1127550, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37305052
13.
Routine health data describe adherence and persistence patterns for oral diabetes medication for a virtual cohort in the Khayelitsha sub-district of Cape Town, South Africa.
PLOS Glob Public Health
; 3(12): e0002730, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38127875
14.
Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa.
Int J Infect Dis
; 127: 63-68, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36436752
15.
Adherence to a care bundle for Staphylococcus aureus bacteraemia: A retrospective cohort study.
S Afr J Infect Dis
; 37(1): 445, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36483573
16.
A Delphi study to guide the development of a clinical indicator tool for palliative care in South Africa.
Afr J Prim Health Care Fam Med
; 14(1): e1-e7, 2022 May 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35695438
17.
Assessing the clinical severity of the Omicron variant in the Western Cape Province, South Africa, using the diagnostic PCR proxy marker of RdRp target delay to distinguish between Omicron and Delta infections - a survival analysis.
Int J Infect Dis
; 118: 150-154, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35235826
18.
Higher mortality associated with the SARS-CoV-2 Delta variant in the Western Cape, South Africa, using RdRp target delay as a proxy: a cross-sectional study.
Gates Open Res
; 6: 117, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-37994361
19.
Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial.
Eur J Heart Fail
; 24(10): 1805-1812, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36073143
20.
Novel Indices of Cognitive Impairment and Incident Cardiovascular Outcomes in the REWIND Trial.
J Clin Endocrinol Metab
; 107(8): e3448-e3454, 2022 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35446415